Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury (original) (raw)

Lung Natural Killer Cells Play a Major Counter-Regulatory Role in Pulmonary Vascular Hyperpermeability After Myocardial Infarction

Keiichi Fukuda

Circulation Research, 2013

View PDFchevron_right

Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients

Salome Bellido

Respiratory Research, 2020

View PDFchevron_right

Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer

Timothy Bullock

Proceedings of the National Academy of Sciences

View PDFchevron_right

Role of natural killer cells in lung cancer

Ayşe Bilge Öztürk

Journal of cancer research and clinical oncology, 2018

View PDFchevron_right

NKG2D Mediates NK Cell Hyperresponsiveness and Influenza-Induced Pathologies in a Mouse Model of Chronic Obstructive Pulmonary Disease

Mauricio Orozco-Levi

The Journal of Immunology, 2012

View PDFchevron_right

NK Cells in the Human Lungs

Jules Russick

Frontiers in Immunology, 2019

View PDFchevron_right

Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation⋆

Nadia Guerra

Journal of Allergy and Clinical Immunology, 2014

View PDFchevron_right

NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells

Jiacheng Bi

Journal of immunology (Baltimore, Md. : 1950), 2017

View PDFchevron_right

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies

Jean-Charles Grivel

Frontiers in Immunology, 2015

View PDFchevron_right

Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C

Erene Niemi

Journal of Immunology, 1997

View PDFchevron_right

Natural killer cells: In health and disease

Arundhati Mandal

Hematology/Oncology and Stem Cell Therapy, 2015

View PDFchevron_right

Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases

Marco Tremolati

Journal of Immunology Research, 2017

View PDFchevron_right

Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune‐therapeutic strategies in cancer therapy

Emanuela Marcenaro

Journal of Leukocyte Biology, 2019

View PDFchevron_right

Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer

Al Sy

Immunology, 2011

View PDFchevron_right

Natural Killer Cells as a Further Insight into the Course of Chronic Obstructive Pulmonary Disease

Tomasz Trafas

Biomedicines, 2024

View PDFchevron_right

Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer

Elizabeth Fabre

OncoImmunology

View PDFchevron_right

Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?

Jean Marc Cavaillon

Critical Care, 2013

View PDFchevron_right

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

Sophie Hue

European Journal of Immunology, 2004

View PDFchevron_right

NK Cells and Polymorphonuclear Neutrophils Are Both Critical for IL-2-Induced Pulmonary Vascular Leak Syndrome

E. Assier

The Journal of Immunology, 2004

View PDFchevron_right

Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69 − CD56 dim cells

Puran Chen

Journal of Allergy and Clinical Immunology, 2017

View PDFchevron_right

Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade

Michelle Gleason

Biology of Blood and Marrow Transplantation, 2010

View PDFchevron_right

Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway

Paul Reynolds

Respirology, 2013

View PDFchevron_right

Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury

Ashish Sharma

American journal of respiratory and critical care medicine, 2011

View PDFchevron_right

Natural killer cells and nitric oxide

Grazia Cifone

International Immunopharmacology, 2001

View PDFchevron_right

Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris

Feifei Huang

International journal of clinical and experimental pathology, 2015

View PDFchevron_right

Licensed to Kill: Towards Natural Killer Cell Immunotherapy

Arnold van der Meer

New Advances in Stem Cell Transplantation, 2012

View PDFchevron_right

Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice

Annette Pexa

Hepatology, 2010

View PDFchevron_right

The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review

Josip A. Borovac

Biomolecules

View PDFchevron_right

Immune surveillance of unhealthy cells by natural killer cells

Alexandre Iannello

Cold Spring Harbor symposia on quantitative biology, 2013

View PDFchevron_right

Functions of natural killer cells

M. Baratin

Nature Immunology, 2008

View PDFchevron_right

Pulmonary Natural Killer T Cells Play an Essential Role in Mediating Hyperoxic Acute Lung Injury

Simon Robson

American Journal of Respiratory Cell and Molecular Biology, 2013

View PDFchevron_right

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment

Lotte Wieten

Frontiers in Immunology, 2018

View PDFchevron_right

Leukemia Inhibitory Factor Suppresses NKG2D mRNA Expression and Presentation on Human Natural Killer Cells

ali khodadadi

Iranian Journal of Allergy, Asthma and Immunology, 2021

View PDFchevron_right

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions

Jules Russick

Journal for ImmunoTherapy of Cancer, 2020

View PDFchevron_right

The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer

Carlo Capella

Neoplasia (New York, N.Y.), 2013

View PDFchevron_right